ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis
SHENZHEN,China,Dec. 12,2024-- Saint-Gobain Group,a global leader in lightweight and sustainable construction solutions,reinvested in the Luohu district of Shenzhen this year.
CHONGQING,China,Dec. 12,2024-- Recently,Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co.,Ltd. ("Aojin Life Sciences")
XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
BEIJING,Dec. 12,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd.,a Fujian-based traditional Chinese medicine (TCM) company,has been striving to expand its overseas markets,enhancing the influen
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
